Lucid Diagnostics Inc. LUCD NASDAQ

Lucid Diagnostics Inc. (LUCD) reported total assets of $40.45M and total liabilities of $29.51M for quarter ending 2025-12-31, resulting in total equity of $10.94M.

The company held $34.71B in cash and short-term investments. Total debt stood at $25.82M, with net debt of $-34.68B. The Debt-to-Equity (D/E) ratio was 2.36 (leveraged).

Current ratio is 1.31, suggesting adequate short-term liquidity. Interest coverage is -7x (weak).

Criteria supported by this page:

• HEALTH (17/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (15/100) — Total assets $40.45M and equity $10.94M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 2.36 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 43/100 with 2/7 criteria passed.